Unlike their biotech counterparts, pharmaceutical companies have largely surpassed analyst expectations on earnings per share during the third quarter. Yet, pharma stocks have not been immune to the stock market swoon of recent weeks.
{iframe}https://www.genengnews.com/lists/top-10-pharma-companies-of-2018/{/iframe}